Zicam has been one of the highest-selling over-the-counter cold medications on the market in recent years, and its manufacturer, Matrixx Initiatives, has enjoyed a solid stock value as a result. However, that all changed today as the company received a letter from the US Food and Drug Administration ordering the company to stop marketing Zicam [...]
Continue reading...
Tuesday, June 16, 2009
1 Comment